Oppenheimer Asset Management’s Biogen BIIB Stock Holding History

Oppenheimer Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-35,928	Closed	-$6.96M	–	1157
2024 Q3	$6.96M	Sell	35,928 -839	-2%	-$163K	0.08%	255
2024 Q2	$8.52M	Buy	36,767 +2,787	+8%	+$646K	0.11%	218
2024 Q1	$7.33M	Sell	33,980 -4,619	-12%	-$996K	0.11%	214
2023 Q4	$9.99M	Sell	38,599 -2,796	-7%	-$724K	0.14%	180
2023 Q3	$10.6M	Buy	41,395 +123	+0.3%	+$31.6K	0.16%	151
2023 Q2	$11.8M	Sell	41,272 -410	-1%	-$117K	0.17%	142
2023 Q1	$11.6M	Sell	41,682 -494	-1%	-$137K	0.18%	140
2022 Q4	$11.7M	Sell	42,176 -5,023	-11%	-$1.39M	0.19%	147
2022 Q3	$12.6M	Buy	47,199 +1,407	+3%	+$376K	0.22%	111
2022 Q2	$9.34M	Sell	45,792 -61	-0.1%	-$12.4K	0.16%	159
2022 Q1	$9.66M	Buy	45,853 +275	+0.6%	+$57.9K	0.14%	181
2021 Q4	$10.9M	Sell	45,578 -6,960	-13%	-$1.67M	0.15%	168
2021 Q3	$14.9M	Buy	52,538 +2,575	+5%	+$729K	0.21%	114
2021 Q2	$17.3M	Buy	49,963 +3,626	+8%	+$1.26M	0.25%	91
2021 Q1	$13M	Buy	46,337 +2,577	+6%	+$721K	0.2%	123
2020 Q4	$10.7M	Buy	43,760 +3,380	+8%	+$828K	0.18%	141
2020 Q3	$11.5M	Buy	40,380 +2,015	+5%	+$572K	0.22%	114
2020 Q2	$10.3M	Buy	38,365 +4,907	+15%	+$1.31M	0.21%	121
2020 Q1	$10.6M	Buy	33,458 +2,623	+9%	+$830K	0.26%	100
2019 Q4	$9.15M	Buy	30,835 +285	+0.9%	+$84.6K	0.19%	134
2019 Q3	$7.11M	Buy	30,550 +2,693	+10%	+$627K	0.16%	169
2019 Q2	$6.52M	Buy	27,857 +5,526	+25%	+$1.29M	0.14%	181
2019 Q1	$5.28M	Buy	22,331 +2,932	+15%	+$693K	0.12%	212
2018 Q4	$5.84M	Buy	19,399 +695	+4%	+$209K	0.14%	170
2018 Q3	$6.61M	Sell	18,704 -1,321	-7%	-$467K	0.15%	169
2018 Q2	$5.81M	Buy	20,025 +2,697	+16%	+$783K	0.14%	179
2018 Q1	$4.75M	Buy	17,328 +2,483	+17%	+$680K	0.12%	217
2017 Q4	$4.65M	Hold	14,845	–	–	0.12%	189
2017 Q3	$4.65M	Buy	14,845 +236	+2%	+$73.9K	0.12%	191
2017 Q2	$3.97M	Sell	14,609 -655	-4%	-$178K	0.11%	218
2017 Q1	$4.17M	Buy	+15,264	New	+$4.17M	0.12%	199